User:Erchan19/sandbox

In response to a movement in the United States supporting the opening of safe injection or consumption sites, states such as New Mexico and cities including Seattle, San Francisco, Ithaca, New York City, and Philadelphia have convened task forces to study the feasibility and impact of these sites and to make recommendations. Many of these efforts have been part of larger harm reduction programs focused on reducing prescription opiate and heroin abuse. As part of their evaluation, San Francisco considered the healthcare impact on its citizens, such as lives saved, hospital stays, and cases of HIV and hepatitis C. The city also conducted surveys to gather opinion from residents and business owners on these facilities. A cost-benefit analysis of a supervised injection site there has been completed. Elsewhere, harm reduction coalitions, academic public health researchers, nonprofit organizations, and professional medical societies have made contributions to understanding the roles of these facilities in harm reduction. In Baltimore researchers at Johns Hopkins University published a report commissioned by the Abell Foundation with their recommendations for opening facilities in the city. In Boston the Massachusetts Medical Society adopted a resolution supporting a pilot program led by the state to examine the impact of these sites on lives saved.